Liver transplant‐free survival according to alkaline phosphatase and GLOBE score in patients with primary biliary cholangitis treated with ursodeoxycholic acid

Goals of Treatment for Improved Survival in Primary Biliary Cholangitis

(2020) Carla F. Murillo Perez et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Definition and Management of Patients With Primary Biliary Cholangitis and an Incomplete Response to Therapy

(2020) Aldo J. Montano-Loza et al.   Clinical Gastroenterology and Hepatology

Effects of Age and Sex of on Response to Ursodeoxycholic Acid and Transplant-free Survival in Patients With Primary Biliary Cholangitis

(2019) Angela C. Cheung et al.   Clinical Gastroenterology and Hepatology

Ursodeoxycholic acid therapy and liver transplant-free survival in patients with primary biliary cholangitis

(2019) Maren H. Harms et al.   JOURNAL OF HEPATOLOGY

Fibrosis stage is an independent predictor of outcome in primary biliary cholangitis despite biochemical treatment response

(2019) Carla F. Murillo Perez et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Number needed to treat with ursodeoxycholic acid therapy to prevent liver transplantation or death in primary biliary cholangitis

(2019) Maren H Harms et al.   GUT

A Placebo-Controlled Trial of Bezafibrate in Primary Biliary Cholangitis

(2018) Christophe Corpechot et al.   NEW ENGLAND JOURNAL OF MEDICINE

Primary Biliary Cholangitis: 2018 Practice Guidance from the American Association for the Study of Liver Diseases

(2018) Keith D. Lindor et al.   HEPATOLOGY

Geoepidemiology, clinical manifestations and outcome of primary biliary cholangitis in Greece

(2017) Nikolaos K. Gatselis et al.   European Journal of Internal Medicine

EASL Clinical Practice Guidelines: The diagnosis and management of patients with primary biliary cholangitis

(2017) Gideon M. Hirschfield et al.   JOURNAL OF HEPATOLOGY

A Placebo-Controlled Trial of Obeticholic Acid in Primary Biliary Cholangitis

(2016) Frederik Nevens et al.   NEW ENGLAND JOURNAL OF MEDICINE

Development and Validation of a Scoring System to Predict Outcomes of Patients With Primary Biliary Cirrhosis Receiving Ursodeoxycholic Acid Therapy

(2015) Willem J. Lammers et al.   GASTROENTEROLOGY

The UK-PBC risk scores: Derivation and validation of a scoring system for long-term prediction of end-stage liver disease in primary biliary cholangitis

(2015) Marco Carbone et al.   HEPATOLOGY

P1198 : Histological stage is relevant for risk-stratification in primary biliary cirrhosis

(2015) M. Carbone et al.   JOURNAL OF HEPATOLOGY

Primary biliary cirrhosis

(2015) Elizabeth J Carey et al.   LANCET

Levels of Alkaline Phosphatase and Bilirubin Are Surrogate End Points of Outcomes of Patients With Primary Biliary Cirrhosis: An International Follow-up Study

(2014) Willem J. Lammers et al.   GASTROENTEROLOGY

Early primary biliary cirrhosis: Biochemical response to treatment and prediction of long-term outcome

(2011) Christophe Corpechot et al.   JOURNAL OF HEPATOLOGY

Baseline Ductopenia and Treatment Response Predict Long-Term Histological Progression in Primary Biliary Cirrhosis

(2010) Teru Kumagi et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Improved Prognosis of Patients With Primary Biliary Cirrhosis That Have a Biochemical Response to Ursodeoxycholic Acid

(2009) Edith M.M. Kuiper et al.   GASTROENTEROLOGY

Biochemical response to ursodeoxycholic acid and long-term prognosis in primary biliary cirrhosis

(2008) Christophe Corpechot et al.   HEPATOLOGY